Airway Disease Treatment Market Share and Growth Factors Impact Analysis 2032

 The global airway disease treatment market is projected to amass a revenue of around US$ 3,495.3 million by 2032, up from US$ 1,996.1 million in 2022 moving forward with a CAGR of 5.2% during the forecast period.

LABA-ICS, LAMA-ICS, triple treatment, and other related drugs are among the pharmaceuticals used in combination therapy for COPD. Combination therapy is gaining popularity due to its greater efficacy to utilising a bronchodilator and a corticosteroid separately, which is driving the demand for treatments for airway diseases.

Due to an increase in patients who are successfully treated with combination therapy but who did not respond to bronchodilators or corticosteroid therapies, the market for treating airway diseases is expected to grow.

Additionally, the use of airway disease treatment is on the rise since combination therapy is more effective than monotherapy at improving the symptoms and quality of life of people with chronic obstructive lung disease.

Due to recent regulatory approvals and an increase in the success rate of the COPD treatment, combination therapy has also gained popularity, benefiting the market as a whole. Another important aspect influencing market trends and predictions for the treatment of airway diseases is the development of innovative medicines for asthma by significant market participants.

Market traits like strong and effective R&D activities help the adoption of airway disease treatments. The engagement of well-known pharmaceutical companies in the development of asthma drugs, which is a chronic disease that affects a considerable number of patients globally, is one of the key trends in the market for treating airway diseases.

The Competition In The Airway Disease Treatment Market

Currently, the global airway disease treatment market is highly competitive owing to the involvement of many established players.

Some of the key players in the global airway disease treatment market are:  Holaira, Inc., VIDA Diagnostics, Boehringer Ingelheim International GmBH, AstraZeneca, Teva Pharmaceuticals, GlaxoSmithKline and Novartis.

Some of the recent developments in the airway disease treatment market are:

  • Tudorza, also known as Eklira, and Duaklir distribution rights were sold by AstraZeneca for US$ 270 million to the Swiss pharmaceutical company Covis Pharma Group.

These medications are intended to treat chronic obstructive pulmonary disease (COPD).

  • The generic albuterol inhaler made by Cipla received regulatory approval from the U.S. FDA in response to the COVID-19 crisis-related shortages of asthma medications.

For people with asthma, this drug is frequently regarded as a last resort.

Key Segments Profiled In The Airway Disease Treatment Market Survey

By Type:

  • Asthma
  • Chronic Obstructive Pulmonary Disorder
  • Bronchiectasis

By Treatment:

  • Bronchodilators
  • Corticosteroids
  • Cytotoxic Drugs
  • Oxygen Therapy
  • Antibiotics
  • Others

By End Use:

  • Hospitals
  • Clinics
  • ASCs
  • Rehabilitation Centres
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Comments

Post a Comment

Popular posts from this blog

Urgent Care Market Analysis by Size, Share, Growth, Trends up to 2032

  Between 2022 and 2032, the   urgent care market demand   is anticipated to increase globally at a moderate CAGR of roughly 5.4%, resulting in sizable revenues by the end of the projection period (2032). Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Urgent Care Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast.   The team of analysts at Future Market Insights are focussing on research and market study to produce different Urgent Care Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Urgent Care Market. Key Players The writer will create content on the general strategies o
Read more

Automotive Brake System & Components Market Revenue, Future And Business Analysis By Forecast 2032

 The global  automotive brake system & components market  is expected to showcase opulent growth over the forecast period from 2022 to 2032 by generating a stable CAGR of 4.7%. The global market is estimated to be valued at US$ 66,414.8 Mn in 2022 and is expected to reach a valuation of US$ 105,131.2 Mn by 2032. As per the historical analysis, from 2017 to 2021, the automotive brake system & components market registered a stagnant growth at 1.0% CAGR but over the years, the market exhibited phenomenal growth and the CAGR reached 4.7% in the forecast period (2022-2032). This year-on-year growth in 2022 is attributed to the surging number of government initiatives in various countries in order to attract the attention of car owners toward vehicle safety. Government bodies are either promoting awareness regarding safety issues or enforcing stringent legislation. Widespread acceptance of luxury  hybrid vehicles , along with enforcement of several safety regulations and surging util
Read more

Dental Burs Market | Growth Opportunities, Business Insights And Forecast To 2032

With an anticipated market value of over  US$ 139.2 Million as of 2022 , the demand for  dental burs market size   is expected to experience a significant CAGR growth value of about  7.8%  from 2022 to 2032, reaching an estimated market value of  US$ 295.6 Million in 2032.  Specialty clinics will account for a significant 40.1% of the end-user sector of the global market in 2021, according to forecasts from Future Market Insights. Over the last two decades, the frequency of dental disorders such as gum disease, dental crack, periodontal disease, and dental cavities has been on the rise. This is expected to boost the worldwide dental burs market. Dentin removal, cutting hard tissues, implantology, cavity preparation and other procedures need the use of dental burs, which are frequently made of stainless steel, tungsten carbide, and diamond grit. The most common and preventable dental condition is dental caries. This factor is associated with changing lifestyles as well as individual eat
Read more